as on November 28, 2025 at 10:37 pm IST
Day's High
5.70%
Upside
52 Week's Low
52 Week's High
88.93%
Downside
4.01%
Upside
Check Palvella Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
-3.5
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-301.19%
Compare market cap, revenue, PE, and other key metrics of Palvella Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $1.2B | NA | NA | 0.00% | |
| BUY | $43.6B | 413.84% | -16.34 | -264.83% | |
| BUY | $58.8B | 242.77% | 1435.87 | 1.36% | |
| BUY | $110.8B | 90.63% | 30.22 | 31.35% | |
| BUY | $83.2B | 52.63% | 18.87 | 32.13% |
Search interest for Palvella Therapeutics, Inc. Stock has increased by 161% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:161% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, PVLA has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 1 year, PVLA stock has moved up by 494.1%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 1006.1% return, outperforming this stock by 982.3%
Revenue Fall
![]()
Revenue is down for the last 4 quarters, 20.05M → 53.0K (in $), with an average decrease of 64.0% per quarter
Profit Down
![]()
Netprofit is down for the last 4 quarters, -3.95M → -11.34M (in $), with an average decrease of 47.6% per quarter
| Organisation | Palvella Therapeutics, Inc. |
| Headquarters | 125 Strafford Avenue, Wayne, PA, United States, 19087 |
| CEO | Mr. Wesley H. Kaupinen |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Wesley H. Kaupinen | Founder, President, CEO & Director |
Mr. Jason Burdette | SVP of CMC & Technical Operations |
Ms. Kathleen Goin | Chief Operating Officer |
Dr. Jeffrey Martini Ph.D. | Chief Scientific Officer |
Mr. Matthew E. Korenberg | CFO & Treasurer |
Ms. Bohan Wei | Vice President of Corporate Development & New Product Planning |
Ms. Emily Cook | Senior Vice President of Clinical Operations |
Ms. Ashley Kline | Chief Commercial Officer |
Dr. David W. Osborne Ph.D. | Chief Innovation Officer |
Palvella Therapeutics, Inc. share price today is $100.87 as on . Palvella Therapeutics, Inc. share today touched a day high of $106.62 and a low of $100.87.
Palvella Therapeutics, Inc. share touched a 52 week high of $104.91 on and a 52 week low of $11.17 on . Palvella Therapeutics, Inc. stock price today i.e. is trending at $100.87,which is 3.85% down from its 52 week high and 803.04% up from its 52 week low.
Palvella Therapeutics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Palvella Therapeutics, Inc. (PVLA) shares with as little as ₹89.436 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹894.36 in Palvella Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Palvella Therapeutics, Inc. share’s latest price of $100.87 as on November 28, 2025 at 10:37 pm IST, you will get 0.0991 shares of Palvella Therapeutics, Inc.. Learn more about
fractional shares .